Crossmark

Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-024-08224-4

Published Online: 2024-06-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marian, Ioana R. http://orcid.org/0000-0002-0692-8112
Ooms, Alexander

Holmes, Jane

Parkes, Matthew J.

Lamb, Alastair D.

Bryant, Richard J.
Funding

Funding for this research was provided by:

Health Technology Assessment Programme (NIHR131233)
License Information

Text and Data Mining valid from 2024-06-14

Version of Record valid from 2024-06-14
More Information

Article History

Received: 2 February 2024

Accepted: 3 June 2024

First Online: 14 June 2024

Declarations

:

: The TRANSLATE trial has approval from the Oxford C Research Ethics Committee (REC: 21/SC/0271). Informed consent from all study participants was sought and obtained by a research facilitator trained in Good Clinical Practice (GCP). Participant data was only collected after consent was obtained.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below